Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation

Adlkofer, 1995, Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice, Nat. Genet., 11, 274, 10.1038/ng1195-274 Adlkofer, 1997, Heterozygous peripheral myelin protein 22-deficient mice are affected by a progressive demyelinating tomaculous neuropathy, J. Neurosci., 17, 4662, 10.1523/JNEUROSCI.17-12-04662.1997 Adlkofer, 1997, Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele, J. Neurosci. Res., 49, 671, 10.1002/(SICI)1097-4547(19970915)49:6<671::AID-JNR2>3.0.CO;2-4 Baechner, 1995, Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development, J. Neurosci. Res., 42, 733, 10.1002/jnr.490420602 Bard, 1996, Cloning and characterization of ERG25, the Saccharomyces cerevisiae gene encoding C-4 sterol methyl oxidase, Proc. Natl. Acad. Sci. U. S. A., 93, 186, 10.1073/pnas.93.1.186 Barone, 1994, Id proteins control growth induction in mammalian cells, Proc. Natl. Acad. Sci. U. S. A., 91, 4985, 10.1073/pnas.91.11.4985 Bascles, 1992, Expression of the PMP-22 gene in Trembler mutant mice: comparison with the other myelin protein genes, Dev. Neurosci., 14, 336, 10.1159/000111680 Berger, 2004, Expression analysis of the N-Myc Downstream-Regulated Gene (NDRG1) indicates that myelinating Schwann cells are the primary disease target in hereditary motor and sensory neuropathy-Lom, Neurobiol. Dis., 17, 290, 10.1016/j.nbd.2004.07.014 Bermingham, 2002, Identification of genes that are downregulated in the absence of the POU domain transcription factor pou3f1 (Oct-6 Tst-1, SCIP) in sciatic nerve, J. Neurosci., 22, 10217, 10.1523/JNEUROSCI.22-23-10217.2002 Brancolini, 2000, Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot–Marie–Tooth type 1A and Dejerine–Sottas diseases, Mol. Biol. Cell, 11, 2901, 10.1091/mbc.11.9.2901 Buchstaller, 2004, Efficient isolation and gene expression profiling of small numbers of neural crest stem cells and developing Schwann cells, J. Neurosci., 24, 2357, 10.1523/JNEUROSCI.4083-03.2004 Costigan, 2002, Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury, BMC Neurosci., 3, 16, 10.1186/1471-2202-3-16 Cummings, 1998, Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1, Nat. Genet., 19, 148, 10.1038/502 Cummings, 2001, Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice, Hum. Mol. Genet., 10, 1511, 10.1093/hmg/10.14.1511 Dahlquist, 2002, GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways, Nat. Genet., 31, 19, 10.1038/ng0502-19 Dashiell, 1997, Dibutyryl cyclic AMP and inflammatory cytokines mediate C3 expression in Schwann cells, Glia, 20, 308, 10.1002/(SICI)1098-1136(199708)20:4<308::AID-GLIA4>3.0.CO;2-1 de Jonge, 2004, Expression of complement components in the peripheral nervous system, Hum. Mol. Genet., 13, 295, 10.1093/hmg/ddh029 Doniger, 2003, MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data, Genome Biol., 4, R7, 10.1186/gb-2003-4-1-r7 Fabbretti, 1995, Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A, Genes Dev., 9, 1846, 10.1101/gad.9.15.1846 Fortun, 2003, Emerging role for autophagy in the removal of aggresomes in Schwann cells, J. Neurosci., 23, 10672, 10.1523/JNEUROSCI.23-33-10672.2003 Fu, 1998, Control of cholesterol biosynthesis in Schwann cells, J. Neurochem., 71, 549, 10.1046/j.1471-4159.1998.71020549.x Garbay, 1989, Developmental expression of the P0 glycoprotein and basic protein mRNAs in normal and trembler mutant mice, J. Neurochem., 53, 907, 10.1111/j.1471-4159.1989.tb11790.x Gaylor, 2002, Membrane-bound enzymes of cholesterol synthesis from lanosterol, Biochem. Biophys. Res. Commun., 292, 1139, 10.1006/bbrc.2001.2008 Haney, 1996, Ultrastructural distribution of PMP22 in Charcot–Marie–Tooth disease type 1A, J. Neuropathol. Exp. Neurol., 55, 290, 10.1097/00005072-199603000-00004 Henry, 1988, Long lives for homozygous trembler mutant mice despite virtual absence of peripheral nerve myelin, Science, 241, 344, 10.1126/science.3388045 Hoffmann, 2002, Changes in gene expression profiles in developing B cells of murine bone marrow, Genome Res., 12, 98, 10.1101/gr.201501 Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J. Clin. Invest., 109, 1125, 10.1172/JCI0215593 Ignatius, 1986, Expression of apolipoprotein E during nerve degeneration and regeneration, Proc. Natl. Acad. Sci. U. S. A., 83, 1125, 10.1073/pnas.83.4.1125 Ionasescu, 1997, Dejerine–Sottas neuropathy in mother and son with same point mutation of PMP22 gene, Muscle Nerve, 20, 97, 10.1002/(SICI)1097-4598(199701)20:1<97::AID-MUS13>3.0.CO;2-Z Isaacs, 2002, Identification of a new Pmp22 mouse mutant and trafficking analysis of a Pmp22 allelic series suggesting that protein aggregates may be protective in Pmp22-associated peripheral neuropathy, Mol. Cell. Neurosci., 21, 114, 10.1006/mcne.2002.1158 Ishida, 2001, Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis, Mol. Cell. Biol., 21, 4684, 10.1128/MCB.21.14.4684-4699.2001 Jaegle, 1998, Role of Oct-6 in Schwann cell differentiation, Microsc. Res. Tech., 41, 372, 10.1002/(SICI)1097-0029(19980601)41:5<372::AID-JEMT4>3.0.CO;2-S Jetten, 2000, The peripheral myelin protein 22 and epithelial membrane protein family, Prog. Nucleic Acid Res. Mol. Biol., 64, 97, 10.1016/S0079-6603(00)64003-5 Kamholz, 1999, Regulation of myelin-specific gene expression. Relevance to CMT1, Ann. N. Y. Acad. Sci., 883, 91, 10.1111/j.1749-6632.1999.tb08572.x Karlsson, 1999, Elevated level of gas3 gene expression is correlated with G0 growth arrest in human fibroblasts, Cell Biol. Int., 23, 351, 10.1006/cbir.1999.0367 Kuhlenbaumer, 2002, Clinical features and molecular genetics of hereditary peripheral neuropathies, J. Neurol., 249, 1629, 10.1007/s00415-002-0946-3 Lasorella, 1996, Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins, Mol. Cell. Biol., 16, 2570, 10.1128/MCB.16.6.2570 Leonhard, 2002, Lesion response of long-term and recently immigrated resident endoneurial macrophages in peripheral nerve explant cultures from bone marrow chimeric mice, Eur. J. Neurosci., 16, 1654, 10.1046/j.1460-9568.2002.02236.x Li, 1996, Characterization of yeast methyl sterol oxidase (ERG25) and identification of a human homologue, J. Biol. Chem., 271, 16927, 10.1074/jbc.271.28.16927 Li, 2001, Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection, Proc. Natl. Acad. Sci. U. S. A., 98, 31, 10.1073/pnas.011404098 Li, 2001, Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application, Genome Biol., 2 Liu, 1999, The gene mutated in bare patches and striated mice encodes a novel 3beta-hydroxysteroid dehydrogenase, Nat. Genet., 22, 182, 10.1038/9700 Lupski, 1992, Gene dosage is a mechanism for Charcot–Marie–Tooth disease type 1A, Nat. Genet., 1, 29, 10.1038/ng0492-29 Magyar, 1996, Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage, J. Neurosci., 16, 5351, 10.1523/JNEUROSCI.16-17-05351.1996 Maier, 2003, Distinct elements of the peripheral myelin protein 22 (PMP22) promoter regulate expression in Schwann cells and sensory neurons, Mol. Cell. Neurosci., 24, 803, 10.1016/S1044-7431(03)00246-X Mandemakers, 1999, Transcriptional regulation of the POU gene Oct-6 in Schwann cells, Adv. Exp. Med. Biol., 468, 13, 10.1007/978-1-4615-4685-6_2 Marber, 1995, Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury, J. Clin. Invest., 95, 1446, 10.1172/JCI117815 Misko, 2002, Matrix metalloproteinase mediated degradation of basement membrane proteins in Trembler J neuropathy nerves, J. Neurochem., 83, 885, 10.1046/j.1471-4159.2002.01200.x Monuki, 1989, SCIP: a glial POU domain gene regulated by cyclic AMP, Neuron, 3, 783, 10.1016/0896-6273(89)90247-X Mueller, 2001, Rapid response of identified resident endoneurial macrophages to nerve injury, Am. J. Pathol., 159, 2187, 10.1016/S0002-9440(10)63070-2 Mueller, 2003, Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages, Lab. Invest., 83, 175, 10.1097/01.LAB.0000056993.28149.BF Muller, 2001, E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis, Genes Dev., 15, 267, 10.1101/gad.864201 Naef, 1997, Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies, Mol. Cell. Neurosci., 9, 13, 10.1006/mcne.1997.0604 Niemann, 2000, Uncoupling of myelin assembly and Schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22, J. Neurosci., 20, 4120, 10.1523/JNEUROSCI.20-11-04120.2000 Notterpek, 1997, Upregulation of the endosomal–lysosomal pathway in the trembler-J neuropathy, J. Neurosci., 17, 4190, 10.1523/JNEUROSCI.17-11-04190.1997 Notterpek, 1999, PMP22 accumulation in aggresomes: implications for CMT1A pathology, Neurobiol. Dis., 6, 450, 10.1006/nbdi.1999.0274 Notterpek, 2001, Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia, Proc. Natl. Acad. Sci. U. S. A., 98, 14404, 10.1073/pnas.251548398 Ohashi, 2003, Localization of mammalian NAD(P)H steroid dehydrogenase-like protein on lipid droplets, J. Biol. Chem., 278, 36819, 10.1074/jbc.M301408200 Palumbo, 2002, Peripheral nerve extracellular matrix remodeling in Charcot–Marie–Tooth type I disease, Acta Neuropathol. (Berlin), 104, 287, 10.1007/s00401-002-0558-0 Passage, 2004, Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot–Marie–Tooth disease, Nat. Med., 10, 396, 10.1038/nm1023 Robertson, 1999, Development of early postnatal peripheral nerve abnormalities in Trembler-J and PMP22 transgenic mice, J. Anat., 195, 331, 10.1046/j.1469-7580.1999.19530331.x Roux, 2004, The temporospatial expression of peripheral myelin protein 22 at the developing blood–nerve and blood–brain barriers, J. Comp. Neurol., 474, 578, 10.1002/cne.20154 Ryan, 2002, Aggresome formation in neuropathy models based on peripheral myelin protein 22 mutations, Neurobiol. Dis., 10, 109, 10.1006/nbdi.2002.0500 Sagami, 1993, Geranylgeranyl diphosphate synthase catalyzing the single condensation between isopentenyl diphosphate and farnesyl diphosphate, J. Biochem. (Tokyo), 114, 118, 10.1093/oxfordjournals.jbchem.a124125 Sakakura, 2001, Sterol regulatory element-binding proteins induce an entire pathway of cholesterol synthesis, Biochem. Biophys. Res. Commun., 286, 176, 10.1006/bbrc.2001.5375 Salles, 2003, Acetyl-CoA carboxylase and SREBP expression during peripheral nervous system myelination, Biochim. Biophys. Acta, 1631, 229, 10.1016/S1388-1981(03)00041-6 Sancho, 1999, Distal axonopathy in peripheral nerves of PMP22-mutant mice, Brain, 122, 1563, 10.1093/brain/122.8.1563 Sancho, 2001, Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot–Marie–Tooth disease type 1A, Brain, 124, 2177, 10.1093/brain/124.11.2177 Sanders, 2001, Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins, Biochemistry, 40, 9453, 10.1021/bi010894f Sereda, 1996, A transgenic rat model of Charcot–Marie–Tooth disease, Neuron, 16, 1049, 10.1016/S0896-6273(00)80128-2 Sereda, 2003, Therapeutic administration of progesterone antagonist in a model of Charcot–Marie–Tooth disease (CMT-1A), Nat. Med., 9, 1533, 10.1038/nm957 Snipes, 1986, Nerve injury stimulates the secretion of apolipoprotein E by nonneuronal cells, Proc. Natl. Acad. Sci. U. S. A., 83, 1130, 10.1073/pnas.83.4.1130 Snipes, 1992, Characterization of a novel peripheral nervous system myelin protein (PMP-22/SR13), J. Cell Biol., 117, 225, 10.1083/jcb.117.1.225 Snipes, 1999, The anatomy and cell biology of peripheral myelin protein-22, Ann. N. Y. Acad. Sci., 883, 143, 10.1111/j.1749-6632.1999.tb08577.x Southwood, 2002, The unfolded protein response modulates disease severity in Pelizaeus–Merzbacher disease, Neuron, 36, 585, 10.1016/S0896-6273(02)01045-0 Stevaux, 2002, A revised picture of the E2F transcriptional network and RB function, Curr. Opin. Cell Biol., 14, 684, 10.1016/S0955-0674(02)00388-5 Stevens, 2003, E2F and cell cycle control: a double-edged sword, Arch. Biochem. Biophys., 412, 157, 10.1016/S0003-9861(03)00054-7 Suter, 2003, Disease mechanisms in inherited neuropathies, Nat. Rev., Neurosci., 4, 714, 10.1038/nrn1196 Suter, 1995, Biology and genetics of hereditary motor and sensory neuropathies, Annu. Rev. Neurosci., 18, 45, 10.1146/annurev.ne.18.030195.000401 Suter, 1992, A leucine-to-proline mutation in the putative first transmembrane domain of the 22-kDa peripheral myelin protein in the trembler-J mouse, Proc. Natl. Acad. Sci. U. S. A., 89, 4382, 10.1073/pnas.89.10.4382 Suter, 1992, Trembler mouse carries a point mutation in a myelin gene, Nature, 356, 241, 10.1038/356241a0 Tobler, 1999, Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction, J. Neurosci., 19, 2027, 10.1523/JNEUROSCI.19-06-02027.1999 Valentijn, 1992, Identical point mutations of PMP-22 in Trembler-J mouse and Charcot–Marie–Tooth disease type 1A, Nat. Genet., 2, 288, 10.1038/ng1292-288 Verheijen, 2003, Local regulation of fat metabolism in peripheral nerves, Genes Dev., 17, 2450, 10.1101/gad.1116203 Yoshida, 1997, Structural and evolutionary studies on sterol 14-demethylase P450 (CYP51), the most conserved P450 monooxygenase: II. Evolutionary analysis of protein and gene structures, J. Biochem. (Tokyo), 122, 1122, 10.1093/oxfordjournals.jbchem.a021870 Young, 2003, The causes of Charcot–Marie–Tooth disease, Cell. Mol. Life Sci., 60, 2547, 10.1007/s00018-003-3133-5 Zirlinger, 2001, Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei, Proc. Natl. Acad. Sci. U. S. A., 98, 5270, 10.1073/pnas.091094698 Zoidl, 1995, Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth, EMBO J., 14, 1122, 10.1002/j.1460-2075.1995.tb07095.x Zoidl, 1997, Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22Trembler on cell growth of NIH3T3 fibroblasts, Cell Tissue Res., 287, 459, 10.1007/s004410050770 Zorick, 1996, The transcription factors SCIP and Krox-20 Mark distinct stages and cell fates in Schwann cell differentiation, Mol. Cell. Neurosci., 8, 129, 10.1006/mcne.1996.0052